Cardiac Inflammation Research Group
1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry
(
- Contribution to journal › Article
-
Mark
Cardiac ATP production and contractility are favorably regulated by short-term S100A9 blockade after myocardial infarction
2025) In Journal of Advanced Research(
- Contribution to journal › Article
-
Mark
Calprotectin as a sepsis diagnostic marker in critical care : a retrospective observational study
(
- Contribution to journal › Article
-
Mark
Long-Term Clinical Outcomes After IFR- vs FFR-Guided Coronary Revascularization : Insights From the SWEDEHEART National Registry
(
- Contribution to journal › Article
-
Mark
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study - differences and similarities
2025) In Cardiovascular Research(
- Contribution to journal › Article
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
(
- Contribution to journal › Article
-
Mark
IL1RAP Blockade with a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune Myocarditis
(
- Contribution to journal › Article
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
(
- Contribution to journal › Article
-
Mark
Mechanistic and therapeutic studies in cardiac inflammation
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
(
- Contribution to journal › Article